Details for New Drug Application (NDA): 017079
✉ Email this page to a colleague
NDA 017079 describes HALDOL SOLUTAB, which is a drug marketed by Ortho Mcneil Pharm and is included in one NDA. Additional details are available on the HALDOL SOLUTAB profile page.
The generic ingredient in HALDOL SOLUTAB is haloperidol. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the haloperidol profile page.
The generic ingredient in HALDOL SOLUTAB is haloperidol. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the haloperidol profile page.
Summary for 017079
| Tradename: | HALDOL SOLUTAB |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | haloperidol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017079
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
